Industries: Biotech & Pharma
Funding stage: Seed (0.25 M EUR - < 1 M EUR) Founded: 2014 Employees: Undisclosed
Business model: Software licence Target: Business, Consumer
We develop software and IT tools for fine-tuning in vitro diagnostic tests for evaluating cardiovascular risk.
We are continually updating our list of new startups so please let us know if you have recently started one.